CARE 2017

Format:

online

Start Date:

10/16/2017

End Date:

10/15/2020

Location:

Online

Max Credits:

20.00

Credit Type:

CME

MOC

Participation

Program Information

Assess your rheumatology medical knowledge and enhance your patient care. With CARE 2017 you receive:

  • 60 case-based, multiple-choice questions with in-depth answer rationales
  • Images and educational links
  • 20 AMA PRA Category 1 CreditsTM and 20 ABIM MOC points with a passing score of 70% or higher

 

Registration Fees

  • Members - $180
  • Nonmembers - $300
  • FIT Members - $99
  • FIT Nonmembers - $150
  • Program Directors - $99 (email education@rheumatology.org to request a discount code for the reduced rate)

CME and MOC Information

Accreditation Statement

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The ACR designates this enduring material for a maximum of 20 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Claim MOC Points

  • Select the MOC checkbox to claim MOC points equal to the number of CME hours claimed.
  • MOC points are submitted to ABIM each day at 11:30 PM EST. After points are submitted, ABIM will not accept changes.
  • If you are submitting MOC points, check your ABIM Physician Portal 24 - 48 hours after submission to make sure your MOC points are reflected.

Learning Objectives

Upon successful completion of this CME activity, learners should be able to:

  • Recognize clinical presentations of rheumatologic conditions
  • Select appropriate tests in the diagnosis, staging, or follow-up of rheumatologic conditions
  • Recommend appropriate management for rheumatologic conditions
  • Assess risk in rheumatologic conditions
  • Understand pathophysiology and basic science relevant to care of patients with rheumatologic conditions

Release Date: October 16, 2017

Expiration Date: October 15, 2020

Disclosures

Use of Professional Judgment

The CARE Program, including all educational links is intended to be used as a tool to assess the rheumatology base medical knowledge of the learner. The information presented relates to basic principles of diagnosis and therapy, and is meant in no way to substitute for an individual patient assessment based upon the healthcare provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient.

Drugs and Doses

When prescribing medications, the health professional is advised to check the prescribing information accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

ACR Disclosure Statement

The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. The CARE 2017 Program has been independently planned by the Self-Assessment Program Development Group under the Continuous Professional Development Committee, and the ACR Committee on Education.

CARE 2017 Development Faculty Disclosures

See ACR’s ACCME Disclosure Practices

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

 

The faculty reported the following disclosures:

  • Juliet Aizer, MD, MPH, Chair: St. Jude Medical, Inc5
  • William Ayoub, MD: Bristol Myers Squibb8
  • Amy Cannella, MD: No relevant relationships to disclose.
  • Christopher Collins, MD: AbbVie5; AbbVie8; Exagen2; Exagen5; Exagen8; GSK2; GSK5
  • Sam Dalvi, MD: No relevant relationships to disclose.
  • Bryant England, MD: No relevant relationships to disclose.
  • Alan Erickson, MD: No relevant relationships to disclose.
  • Candace Feldman: Bristol-Myers Squibb2; EMD-Serono5; Pfizer2
  • Mark Fisher, MD, MPH: No relevant relationships to disclose.
  • Uzma Haque, MD: No relevant relationships to disclose.
  • Mandana Hashefi, MD: No relevant relationships to disclose.
  • Joel Hirsh, MD: No relevant relationships to disclose.
  • Rumey Ishizawar, MD, PhD: EMD Millipore3(spouse)
  • Arundathi Jayatilleke, MD: No relevant relationships to disclose.
  • Deana Lazaro, MD: No relevant relationships to disclose.
  • Eli Miloslavsky, MD: Genentech2 ; Pfizer5
  • Mathilde Pioro, MD: No relevant relationships to disclose.
  • Jeffrey Potter, MD: No relevant relationships to disclose.
  • Nina Ramessar, MD: No relevant relationships to disclose.
  • Neal Roberts, MD: Novartis1; Johnson & Johnson1; Sanofi1; Gilead Sciences1
  • Angela Robinson, MD, MPH: No relevant relationships to disclose.
  • Beth Rubinstein, MD: No relevant relationships to disclose.
  • Manveen Saluja, MD: No relevant relationships to disclose.
  • Amanda Sammut, MD: No relevant relationships to disclose.
  • Rodney Tehrani, MD: No relevant relationships to disclose.
  • Karina Torralba, MD: GSK5; Pfizer5
  • Christopher Wise, MD: No relevant relationships to disclose.
  • Patrick Wood, MD: No relevant relationships to disclose.
  • Eveline Wu, MD: No relevant relationships to disclose.

Corporate Support

Educational grant support for CARE 2017 provided by Lilly USA, LLC, Sanofi Genzyme and Regeneron Pharmaceuticals, Horizon Pharma, Mallinckrodt Pharmaceuticals, and Celgene Corporation.